Adaptive Oxygen Therapeutics for Specialized Environments
Legal Citation
Summary of the Inventive Concept
An oxygen therapeutic system designed for treating glioblastoma in unique operational environments, such as high-altitude areas, disaster zones, remote locations, high-security facilities, or areas with limited medical infrastructure.
Background and Problem Solved
The original patent disclosed the use of an oxygen therapeutic in combination with repeated administrations of chemotherapy medications and/or radiation therapy. However, the existing approach may not be effective in specialized environments where oxygen levels are compromised or medical resources are limited. The new inventive concept addresses these limitations by adapting the oxygen therapeutic for use in these niche environments.
Detailed Description of the Inventive Concept
The inventive concept comprises a perfluoropentane emulsion administration module, which can be integrated with radiation therapy modules, power sources, and remote monitoring systems. The system is designed to operate in extreme weather conditions, high-altitude environments, and areas with limited medical infrastructure. The perfluoropentane emulsion is administered concomitantly with fractionated radiotherapy or chemotherapy, and the system can be adapted for secure, encrypted communication in high-security environments. The portable, self-contained treatment unit enables administration of the emulsion in disaster-stricken areas.
Novelty and Inventive Step
The new claims introduce novel adaptations of the oxygen therapeutic system for specialized environments, including high-altitude areas, disaster zones, remote locations, high-security facilities, or areas with limited medical infrastructure. The inventive step lies in the integration of the perfluoropentane emulsion administration module with radiation therapy modules, power sources, and remote monitoring systems, enabling effective treatment of glioblastoma in these unique operational environments.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include adapting the oxygen therapeutic system for use in other specialized environments, such as space exploration or underwater operations. Variations of the system may also include different types of oxygen therapeutics or administration methods.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the healthcare industry, particularly in areas with limited medical infrastructure or high-security environments. The system may also be of interest to government agencies, disaster relief organizations, and remote medical providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K41/0038 |
| A | A61 | A61K9/0019 |
| A | A61 | A61K9/107 |
| A | A61 | A61K31/02 |
| A | A61 | A61K33/00 |
| A | A61 | A61K39/395 |
| A | A61 | A61K45/06 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/24 |
| A | A61 | A61K47/26 |
| A | A61 | A61N5/10 |
| A | A61 | A61K2039/505 |
| A | A61 | A61K2039/545 |
| A | A61 | A61N2005/1098 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical oncology and radiotherapy, specifically focused on targeted cancer treatments involving oxygen therapeutics and fractionated radiation therapy for glioblastoma, with expertise in pharmaceutical formulations, drug delivery systems, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A medical professional with advanced training in oncology, radiotherapy techniques, pharmaceutical engineering, with knowledge of perfluorocarbon emulsions, radiation sensitization methods, and medical device adaptation for specialized environments
Obviousness Rationale
A PHOSITA would recognize that adapting the perfluoropentane emulsion treatment method to different operational environments represents a predictable engineering variation that leverages the core therapeutic mechanism disclosed in the source patent. The fundamental chemical and medical principles remain consistent, with modifications primarily addressing deployment and operational constraints. The variations represent logical extensions of the original therapeutic approach, applying known design principles to expand treatment accessibility.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,627 |
|---|---|
| Title | Fractionated radiotherapy and chemotherapy with an oxygen therapeutic |
| Assignee(s) | NuvOx Pharma LLC |